On Thursday, Shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), gained 1.98% to $9.28.
Synergy Pharmaceuticals Inc, declared that its Chairman and Chief Executive Officer, Gary S. Jacob, Ph.D., will present a corporate update at the Cantor Fitzgerald Healthcare Conference on Wednesday, July 8, 2015 at 2:30 p.m. Eastern Time at Le Parker Meridien Hotel in New York City.
A live webcast of the presentation will be accessible through the Investor Relations section of the company’s website at www.synergypharma.com. A replay of the webcast will be accessible on Synergy’s website for 60 days.
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders.
Shares of Franklin Resources, Inc. (NYSE:BEN), declined -0.24% to $49.21, during its last trading session.
Franklin Resources, declared its regular monthly dividend from net investment income of $0.025 per share, payable on July 31, 2015, to shareholders of record on July 17, 2015 (Ex-Dividend Date: July 15, 2015).
The Fund’s investment manager, Franklin Advisers, Inc., is a wholly owned partner of Franklin Resources, Inc. (NYSE: BEN), a global investment administration organization operating as Franklin Templeton Investments. Franklin Templeton Investments provides global and domestic investment administration to retail, institutional and sovereign wealth clients in over 150 countries. Through specialized teams, the company has expertise across all asset classes — counting equity, fixed income, alternative and custom solutions. The company’s more than 600 investment professionals are supported by its integrated, worldwide team of risk administration professionals and global trading desk network. With offices in 35 countries, the California-based company has more than 65 years of investment experience and over $888 billion in assets under administration as of May 31, 2015. For more information, please visit franklintempleton.com.
Franklin Resources, Inc. is a publicly owned asset administration holding company. Through its auxiliaries, the firm provides its services to individuals, institutions, pension plans, trusts, and partnerships.
Finally, Cheniere Energy, Inc.(NYSEMKT:LNG), ended its last trade with 0.06% gain, and closed at $ 68.77.
Cheniere Energy, declared that its Board of Directors has made a positive Final Investment Decision (“FID”) with respect to Train 5 of the Sabine Pass liquefaction project (“Sabine Pass Liquefaction Project”) in Cameron Parish, Louisiana, and has issued a notice to proceed with construction to Bechtel Oil, Gas and Chemicals, Inc. (“Bechtel”). The Sabine Pass Liquefaction Project is being designed for up to six liquefaction trains, each with nominal production capacity of about 4.5 million tonnes per annum (“mtpa”). Train 5 is predictable to commence operations as early as 2018.
“We now have five liquefaction trains under construction at Sabine Pass, with Train 1 predictable to make first LNG later this year. We expect to reach FID on Train 6 at Sabine Pass upon completion of commercial contracts and arranging financing, as all necessary regulatory approvals have been received,” said Charif Souki, Chairman and CEO of Cheniere. “We appreciate all of the time and effort that goes into these projects and would like to thank our employees, contractors, Bechtel, government officials, and our planned partners for their continued dedication and hard work as we proceed with construction on our Sabine Pass Liquefaction Project.”
Cheniere Energy, Inc., an energy company, engages in the liquefied natural gas (LNG) related business. It operates through two segments, LNG Terminal Business, and LNG and Natural Gas Marketing Business.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
